Cite
HARVARD Citation
Schoennemann, K. et al. (n.d.). 2309 Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS2w) administered every second week in patients with advanced gastro-esophageal cancer. European journal of cancer. pp. S435-. [Online].